M&A Deal Summary |
|
---|---|
Date | 2022-11-07 |
Target | NEST New York |
Sector | Consumer Products |
Buyer(s) | North Castle Partners |
Sellers(s) | Eurazeo PME |
Deal Type | Secondary Buyout |
Deal Value | 200M USD |
Advisor(s) | Perella Weinberg Partners (Financial) |
SEARCH BY
Try For Free 7-Day Free Trial
Category | Private Equity Firm |
---|---|
Founded | 1997 |
Size | Middle-Market |
Type | Sector Focused |
North Castle Partners is a specialist private equity firm that targets investments in consumer-driven product and service businesses. North Castle seeks control investments in companies that benefit from consumers looking to live 'healthier' lives as well as businesses that benefit from the baby boomer population. Specific areas of interest include aesthetics and personal care, consumer health, fitness and recreation, home and leisure, and nutrition. North Castle was formed in 1997 and is based in Greenwich, Connecticut.
DEAL STATS | # |
---|---|
Overall | 48 of 48 |
Sector (Consumer Products) | 19 of 19 |
Type (Secondary Buyout) | 4 of 4 |
State (New York) | 10 of 10 |
Country (United States) | 46 of 46 |
Year (2022) | 2 of 2 |
Size (of disclosed) | 1 of 1 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2022-09-20 |
Therabody
Los Angeles, California, United States Therabody is a wellness technology company with a mission to inspire and enable everybody and the mind to keep moving. The company's products and content are embraced by the medical community, sports and beauty industry leaders, and millions of consumers worldwide. Currently available in more than 60 countries, including at company-owned retail stores and at Reset, a whole-body wellness and recovery center, the product line includes proprietary technologies and leverages biometrics for personalized real-time therapies. Therabody was founded in 2007 and is based in Los Angeles, California. |
Buy | - |
Category | Private Equity Firm |
---|---|
Founded | 1997 |
Size | Middle-Market |
Type | Sector Agnostic |
Eurazeo PME, formerly known as OFI Private Equity Capital. Eurazeo PME invests equity and mezzanine capital in secondary buyout transactions of unlisted French companies. The Firm looks for opportunities valued between €50 and €250 million. Areas of interest include chemicals, financial services, consumer services, retail, manufacturing, distribution, and life science. Eurazeo PME was formed in 1997 and is based in Paris.
DEAL STATS | # |
---|---|
Overall | 28 of 29 |
Sector (Consumer Products) | 2 of 2 |
Type (Secondary Buyout) | 16 of 16 |
State (New York) | 1 of 1 |
Country (United States) | 3 of 3 |
Year (2022) | 2 of 2 |
Size (of disclosed) | 6 of 8 |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2022-09-08 |
Imapole
Villeurbanne, France Imapole is a medical imaging group with 24 machines including four scanners and two MRI machines and handles 170,000 patients per year. The main site is connected to Medipole Lyon-Villeurbanne, hospital with 750 beds and a 24/7 emergency department Imapole is at the forefront of the care offering in its catchment area, which is short of imaging capacity. Imapole was founded in 2018 and is based in Villeurbanne, France. |
Buy | - |
DATE | TARGET | DEAL TYPE | VALUE |
---|---|---|---|
2022-11-21 |
NeoXam
Paris, France NeoXam is a provider of investment accounting, investment management, and data management software solutions. NeoXam's customer base is made of large and medium asset management firms, investment banks, institutional investors, and securities services providers. NeoXam was founded in 2014 and is based in Paris, France. |
Buy | - |